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1. Introduction  
In his address on the treatment of breast cancer, delivered in 1894 before the Harveian 
Society of London, W. Watson Chayne said of breast cancer: the “subject cannot be too often 
brought before the notice of the medical public. First, because the disease is common, at any 
rate in certain regions, and seems to be becoming more so”(Cheyne 1894). Although a 
hundred years of extensive research generated 226 946 scientific publications in the period 
1886-2011, breast cancer remains the second leading cause of cancer deaths in women today. 
Breast cancer is the first human tumor for which targeted therapies have been developed. 
The most successful therapies include tamoxifen and aromatase inhibitors – both estrogen 
receptor pathway downregulators – and Herceptin, a HER2 antagonist that prolongs disease 
remission in selected women, but metastatic breast cancer remains largely an incurable 
disease (Imyanitov and Hanson 2004). 
Breast cancer shares all the hallmarks of cancer postulated by Hanahan and Weinberg 
(Hanahan and Weinberg 2000) that include sustaining proliferative signaling, evading 
growth suppressors, resisting cell death, enabling replicative immortality, inducing 
angiogenesis, and activating invasion and metastasis. In addition, recent progress has added 
two further hallmarks such as reprogramming of energy metabolism and evading immune 
destruction (Hanahan and Weinberg 2011). Increasing recognition of the contribution of the 
tumor microenvironment to tumorigenesis re-affirms the concept of cancer as a systemic 
disease with very complex, not yet understood biology.  
In 2011 more than 7 million humans around the world will die of cancer and 465 000 women 
will die from breast cancer alone (Mukherjee 2011).  
For humanity, cancer is still the “Emperor of all maladies, master of all terrors.”(Mukherjee 
2011). For scientists it remains a formidable challenge to understanding the complexity of 
cellular function.  
2. Large-scale proteomics analysis of cancer cells 
The completion of human genome sequencing and rapid development of DNA-microarray 
technology led to extensive investigation of gene expression associated with breast cancer. 
Large-scale screening of mRNA levels showed that multiple and extensive changes in 
mRNA levels are commonly seen in breast cancer (Ince and Weinberg 2002, Sebastian and 
Johnson 2006, Sorlie et al. 2001, van de Vijver et al. 2002). However, eukaryotic cell 
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proliferation is known to involve complex molecular choreography of mitogens that 
stimulate cell growth, membrane receptors, their signaling pathways, and downstream 
effectors of cell division (Hanahan and Weinberg 2000, Sebastian and Johnson 2006). Such 
studies clearly indicated an urgent need for complementary, highly parallel studies at the 
protein level. If genes have “legislative power” much of “executive power” is carried out by 
proteins. Their spatial and temporal distribution within cells is a very complex, but 
essential, feature of cellular function. The analysis of such distributions is complicated by 
the facts that a given protein may have multiple subcellular locations, can exist in multiple 
transcriptional or post-translational isoforms within the same cell and that the different 
isoforms may have different spatial and temporal distributions as well as different 
functional roles (Godovac-Zimmermann et al. 2005, Roberts and Smith 2002). Highly 
parallel methods such as analysis of mRNA abundance can give information on inputs to 
cellular protein abundance but the mRNA methods do not always correlate well with direct 
measurements of protein abundance (Gygi et al. 1999), require additional complexity to 
measure transcriptional isoforms, do not detect post-translational isoforms, and do not give 
information on spatial location. Conversely, direct measurements of spatial location by 
methods such as fluorescence microscopy usually do not distinguish isoforms, are mainly 
semiquantitative, and are difficult to achieve in highly parallel formats. 
2.1 Quantitative proteomics of MCF-7 breast cancer subcellular organelles 
In recent years, considerable effort has been devoted to determining the identities of 
proteins included in different subcellular organelles by proteomics (Au et al. 2007, Rogers 
and Foster 2007, Simpson and Pepperkok 2006, Xu et al. 2009, Yates et al. 2005). The most 
common approach has been purification of individual organelles followed by exhaustive 
determination of the protein content. The main disadvantages of this approach are (a) that 
the degree of purification/contamination of the organelle is difficult to ascertain 
conclusively for lower abundance proteins, (b) that the protein content may be altered by 
the purification process and (c) that the approach is not very suitable for dynamic studies of 
protein subcellular location. In a few cases, (Dunkley et al. 2004, Foster et al. 2006) an 
alternative approach of partial purification of organelles in a sucrose gradient has been 
employed, but the assignment of proteins to individual organelles has been based on 
matching gradient profiles of proteins to the profiles of presumptive marker proteins.  
Although this is useful for identifying what might be denominated core proteins of an 
organelle, it is automatically biased against evaluation of proteins in multiple subcellular 
locations.  
The goal of our work (Qattan et al. 2010) was to establish high throughput proteomics 
methods that are capable of analyzing dynamically at least some of the complexity involved 
in subcellular protein distribution. The estrogen-dependent MCF-7 malignant breast 
epithelial cell line was selected due to the wealth of information available in the literature 
and its relevance to breast cancer (Lacroix and Leclercq 2004, Soule et al. 1973). Proteomics 
methods based on mass spectrometry are only suitable for indirect measurements of spatial 
location and we have therefore concentrated on the distribution of proteins between 
different subcellular organelles. To avoid the need for multiple purification procedures for 
many different organelles, partial purification based on sucrose gradient centrifugation was 
used followed by high throughput proteomics analysis of the protein content of different 
fractions from the sucrose gradient. Figure 1 illustrates the subcellular proteomics 
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workflow. Following subfractionation of cellular organelles by sucrose gradient 
centrifugation, the basic functioning of the method was controlled by biochemical assay 
(Figure 2).   
Enzymatic assays and Western blot detection indicated sucrose gradient fractions enriched 
in cytosol, plasma membrane, endoplasmic reticulum, and mitochondrial proteins, 
respectively. On the basis of this data obtained, fractions of cytosol, plasma membrane, 
endoplasmic reticulum and mitochondria from the sucrose gradient fraction were subjected 
to detailed analysis of protein content by MS methods.  
 
 
Fig. 1. Subcellular organelle proteomics workflow.  
2.1.1 Proteomics data sets show multiple subcellular locations of proteins 
Two aspects of the MS analysis are important in the context of the goals of the present work: 
(1) secure identification of as many proteins as possible in each fraction and (2) accurate 
measurement of the (relative) amount of any specific protein across the different fractions. 
We have used direct spectral counts from MS/MS runs for quantitative measurements of 
the peptides (Usaite et al. 2008). Table 1 shows that that a total of 15 527 different peptides 
were used to identify 2184 proteins in fractions of cytosol (CT), plasma membrane (PM), 
endoplasmic reticulum (ER) and mitochondria (MT). The initial set of MS data contained 
5514 (protein, fraction, abundance) data points for 2184 proteins: there was an average of 2.5 
locations per protein. This initial data set contained a substantial number of (protein, 
fraction, abundance) data points for which in a particular fraction only a single peptide with 
a small number of spectral counts was observed for some proteins. 
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Fig. 2. Subcellular verification of protein markers by enzyme assay and Western blot. A total 
of 24 fractions was collected from a sucrose-density gradient (0.43-1.46 M) in which fractions 
1 and 24 represent the top and the bottom, respectively. Typical density profile of sucrose 
fractions is calculated by refractive indices. Also shown is the distribution of activity across 
the gradient for the subcellular enzyme markers LDH and Cytochrome C oxidase. 
The assignment of these proteins is less certain for these fractions. Removal of 876 data 
points for fractions where only a single peptide and 1 or 2 spectral counts were observed 
gave the normal data set in Table 1. 106 (protein, fraction, abundance) data points with only a 
single peptide in a fraction, but with 3 to 74 spectral counts, were retained to give a total of 
4638 data points. The normal data set, which was used for many of the analyses below, 
corresponds to an average of 2.1 locations per protein. For some of the analyses, we have 
also removed from the normal data set those (protein, fraction, abundance) data points 
where less than 4% of the total amount of a given protein was observed in a specific fraction. 
This trimmed data set reduced the number of data points to 4576, that is, an average of 2.1 
locations per protein.  
In the following we will refer to the three sets of (protein, fraction, abundance) data points 
used for further analysis as the initial, normal and trimmed data sets (Table 1B), all of which 
contain a total of 2184 proteins. For individual proteins that were detected in multiple 
fractions, we will also use the term “primary location” to refer to the (protein, fraction) pair 
with the highest abundance and the term “secondary location” to refer to other (protein, 
fraction) pairs with lesser abundances for the same protein.  
2.1.2 The observation of the same protein in multiple fractions is not due to “tailing” 
of the proteins in the sucrose gradient 
With the normal data set, many of the proteins were observed in more than one sucrose 
gradient fraction and hierarchical clustering was used to analyze their distribution over the 
gradient (Figure 3). This indicated that in many cases the observation of the same protein in 
multiple fractions was not due to “tailing” of the proteins in the sucrose gradient. 
www.intechopen.com
 Quantitative Organelle Proteomics of Protein Distribution in Breast Cancer MCF-7 Cells 
 
207 
 
a Includes all (protein, fraction, spectral counts) data points verified by Scaffold.  
b Number of proteins found only in one fraction.  
c Excludes(protein, fraction, spectral counts) data points where only a single peptide with 1 or 2 spectral 
counts was observed in a specific fraction. 
d After removal from the normal data set of (protein, fraction, abundance) data points for which the 
proportion of the protein in a specific fraction was less than 4% of the total protein abundance in all four 
fractions. 
Table 1. Summary of MS Data  
The data shows numerous examples of bimodal distribution of proteins over two fractions 
that are not adjacent in the gradient (e.g., cytosol and mitochondria fractions in Figure 3C), 
as well as examples of proteins with more complicated bimodal distributions over three of 
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the four fractions (Figure 3B) that are highly unlikely to arise from tailing. A Venn diagram 
(Figure 4) has been used to summarize the observed distribution of the proteins over the 
four sucrose gradient fractions as determined by the hierarchical clustering. A notable 
characteristic for the normal data set is that only 844 of the 2184 proteins (38.6%) were 
uniquely found in a single fraction. A further 296 proteins (13.6%) were found to be 
ubiquitously distributed over all fractions. The remaining 1044 proteins (47.8%) were 
consistent with intermediate distribution over multiple, but not all, subcellular locations. Of 
these 1044 proteins, 248 (11.4% of total proteins) were distributed over two fractions (e.g., 
cytosol and mitochondria, Figure 3C) or over three fractions (e.g., cytosol, membrane 
proteins and mitochondria, Figure 3B) in a “bimodal” manner that is inconsistent with 
inclusion in a single subcellular organelle and “tailing” over the sucrose gradient. 
 
 
 
 
Fig. 3. Hierarchical clustering and heat map across the four fractions. Individual proteins are 
represented by a single row, each fraction is represented by a single column, and each cell 
represents the abundance of a single protein in a single fraction. The color scale is for 
normalized relative abundance from 6.0 (red) to 1.0 (yellow) to 0.0 (blue, not detected). The 
expansions show typical regions of the heat map corresponding to: (a) proteins observed 
uniquely in cytosol, (b) “bimodal” proteins (see text) observed in fractions cytosol (CT), 
plasma membrane (PM), mitochondria (MT), and (c) “bimodal” proteins observed in 
fractions cytosol and mitochondria.  
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Fig. 4. Four-way Venn diagrams summarizing the distribution of the 2184 proteins over 
different combinations of the sucrose gradient fractions.  
2.1.3 The data represent a good sampling of the distribution over multiple subcellular 
locations for the observed proteins 
Inspection of the distribution of the proteins between primary and secondary locations 
revealed that they are well dispersed over the regions compatible with a primary location 
and 1-3 secondary locations (Figure 5). Thus, for example, proteins for which we detected a 
primary location and a single secondary location must lie on the line from (0.5, 0.5) to (1.0, 
0.0) (green plus signs in Figure 5), but are well dispersed along that line. For 2-3 secondary  
 
 
Fig. 5. Distribution of proteins with a primary location and 1 (green), 2 (blue), or 3 (red) 
secondary locations over compatible areas of a plot of primary mole fractions vs secondary 
mole fractions. For each protein, the spectral counts observed in a specific gradient fraction 
were expressed as mole fractions of the total number of spectral counts observed in all four 
gradient fractions.  
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locations, the initial data set shows better sampling near the edges of the compatible regions, 
for example, there are more data points at large values of the primary mole fraction and at 
very small values of the secondary mole fractions. Many of these data points arise from 
proteins corresponding to sequencing of only one peptide and only 1-2 spectral counts in a 
specific fraction. This is a consequence of the sampling properties of spectral counting. The 
dispersion of the data points in Figure 5 over the compatible areas of the plot is a strong 
indication that the data represent a good sampling of the distribution over multiple 
subcellular locations for the observed proteins. 
2.1.4 Spurious tailing of proteins in the sucrose gradient does not make any major 
contributions to the observed multiplicity of locations 
A more quantitative evaluation of the possibility of tailing in the gradient was obtained by 
looking for proteins with high abundance in a given gradient fraction, but with no 
detectable abundance in the adjacent fractions. For the most abundant proteins, the MS 
detection method was capable of detecting as little as about 0.2% of the protein in an 
adjacent fraction. Because the proteins may correspond to different subcellular organelles, 
tailing between two fractions need not be symmetrical, e.g. tailing from CT to PM may not 
be the same as tailing from PM to CT. This leads to the six tests for the possibility of tailing 
shown in Table 2. For all the fractions there are many highly abundant proteins which do 
not tail into the adjacent fraction (Table 2). The highly abundant proteins also reveal some 
characteristics which are common in the data set. Some very abundant proteins were found 
uniquely in a single fraction (e.g., see hepatoma-derived growth factor and Protein S100-A9 
in Table 2). Other proteins were detected in only two fractions, but with a bimodal 
distribution over the fractions (e.g., see sialic acid synthase and pyridoxal kinase in Table 2).  
Many proteins were distributed over several fractions, with substantial proportions of the 
protein present in different fractions (e.g., see ATP-citrate synthase in Table 2). Some 
proteins were primarily present in a single fraction, but small amounts of the protein were 
found in other fractions (see e.g. Rho GDP-dissociation inhibitor 1 and nucleophosmin in 
Table 2). We conclude from the data in Table 2 that spurious tailing of proteins in the 
sucrose gradient does not make any major contributions to the observed multiplicity of 
locations.  
2.1.5 Annotations of subcellular location 
We have used previous subcellular location annotations in the UniProtKB database (in the 
keyword “subcellular location” field and the ontology “subcellular component” field) and in 
the Locate Subcellular Location database to compare three aspects of the present work with 
earlier work: (1) the degree to which the individual sucrose gradient fractions are enriched 
with proteins corresponding to specific subcellular organelles; (2) the extent to which the 
multiplicity of subcellular locations observed here is reflected in current annotations of 
subcellular locations; and, (3) the extent to which there are discrepancies between this work 
and previous annotations of subcellular locations.  
In evaluating these comparisons, it is important to keep in mind that there is not an exact 
mesh between our experimental strategy and the ontological descriptions of subcellular 
location used in the databases. The top level of our experimental design matches the levels 
(extracellular region, plasma membrane, cytoplasm, nucleus) in the GO classification 
scheme, but the experiment excludes the extracellular region and the nucleus. At a lower 
level we only tried to obtain an approximate resolution of the cytoplasm as (cytosol,  
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a Proteins where the name is shown in bold correspond to proteins which exemplify general 
characteristics of the data that are noted in the text. 
b Normalized abundances were calculated from the Spectral Abundance Factor using GeneSpring, that 
is, the abundances have been normalized using a correction for the differing number of amino acids in 
the proteins. For all proteins, the normalized abundances ranged from 0.018 to 22.25. A dash indicates 
the protein was not detected.  
c Selection criteria. A filter to select non detected proteins was applied to a chosen fraction (ND). In an 
adjacent fraction in the sucrose gradient, the proteins were sorted according to abundance and the 
seven most abundant proteins (top) are shown.  
Table 2. Test for overlap of proteins between sucrose gradient fractions 
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endoplasmic reticulum, mitochondria), while the databases typically use (cytoplasm/ 
cytosol, endoplasmic reticulum, mitochondrion, Golgi apparatus). Overall, relative to the 
UniProtKB subcellular locations, 271 proteins had no annotations, 1388 had annotations at 
the top level and 525 had annotations at the lower level. For the 481 (22.0%) proteins in the 
initial data set that were observed in only a single fraction, we compared their locations with 
previous experimental information about subcellular location in the UniProtKB database. 
Figure 6 summarizes the proportion of these “unique” proteins which were previously 
assigned to various subcellular locations. This data provides an overview of the enrichment 
of the four fractions with cytosolic, plasma membrane, endoplasmic reticulum and 
mitochondrial proteins respectively. First, all four fractions show a substantial proportion of 
proteins either for which there is no previous annotation of subcellular location, or for 
which the previous annotation is only nucleus or extracellular region (from 5 (19%) of 
proteins in ER to 83 (40%) of proteins in MT). These annotations are compatible with the 
enrichment of the fractions with their various types of proteins and the present results 
constitute new annotation information for these proteins. Fraction CT shows three other 
major slices: (1) proteins which are fully compatible with cytosolic proteins, (2) proteins 
which have previously been assigned to cytoplasm, but also to other subcellular locations, 
and (3) proteins which have been previously assigned to other subcellular locations, but not 
to cytoplasm or cytosol. There is some ambiguity in the second and third groups since 
cytosol is not distinguished in many experimental strategies and the assigned locations are 
daughters of cytoplasm (but not of cytosol) in the GO ontology. Overall for the 127 proteins 
observed only in fraction CT, 119 (93.7%) have annotations that are compatible with 
enrichment of this fraction with cytosolic proteins. Only 8 proteins (6.3%) appear to be 
discrepancies that have other, incompatible locations. Of the 119 compatible proteins, 16 
proteins have previous annotations that deviate from observation uniquely in fraction CT. 
For the other sucrose gradient fractions the cytoplasm/cytosol distinction also leads to some 
ambiguity, but overall the number/proportion of proteins compatible with enrichment of 
fraction PM (plasma membrane), fraction ER (endoplasmic reticulum) and fraction MT 
(mitochondrion) with the respective protein types are 94 (78.3%), 18 (67.0%), and 184 (88.9%) 
respectively. Because there is some inconsistency between the different subcellular location 
annotation sources , these numbers vary somewhat if the UniProtKB subcellular 
components or the Subcellular Location database are used, but do not change the overall 
conclusion. Within the limitations of such comparisons, we conclude that the previous 
annotations are largely consistent with enrichment of the fractions with the expected protein 
types. Apparent experimental/ database annotation discrepancies for all 2184 proteins are 
considered in more detail below. Is the apparent multiplicity of protein subcellular locations 
observed in our experiments captured in current database annotations? To address this 
question, we used the set of 163 proteins in the initial data set that showed bimodal, 
nonadjacent distributions over the sucrose gradient fractions (includes proteins observed 
only in combinations of non-adjacent fractions CT-ER, CT-MT, PM-MT, CT-PM-MT, and 
CT-ER-MT, i.e. proteins that clearly have multiple locations) and which also had at least 8 
spectral counts. The latter condition ensures that the classification of these proteins as 
bimodal is not unduly influenced by the dynamic range limitations of MS/MS spectral 
counting. This set of proteins was compared with (merged) subcellular location annotations 
from the UniProtKB and LOCATE Subcellular Location databases. Figure 7 shows the 
distribution over the bimodal combinations of fractions and the annotations of subcellular 
location for all 163 proteins. As seen above with the proteins identified in only a single 
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fraction, 59 (36.2%) of the bimodal proteins only had annotation at the level (nucleus, 
extracellular region, no annotation). Furthermore, only 22 (13.5%) of the proteins show 
multiple locations at the annotation level (cytoplasm/cytosol, plasma membrane, 
endoplasmic reticulum, Golgi apparatus, mitochondrion). In general these results are 
consistent with the conclusion that current database annotations of subcellular location are 
sparse and skewed toward single locations for proteins. 
 
 
 
 
 
Fig. 6. Distribution of current subcellular location annotations in the UniProtKB database 
over the proteins observed solely in a single sucrose gradient fraction in the initial data set. 
The annotations are color coded (legend) according to the GO classification levels 
compatible with our experimental strategy (upper: extracellular region, plasma membrane, 
cytoplasm, nucleus; lower: cytosol/cytoplasm, endoplasmic reticulum, Golgi apparatus, 
mitochondrion). A small number of proteins had multiple lower level annotations and are 
shown in the region color coded as multiple. Proteins that had multiple annotations that 
included other locations different from the color code are indicated by the radial letters. The 
heavy white lines delineate slice regions that have different compatibility with the 
experimental data. 
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Fig. 7. Comparison of the present data on subcellular location of bimodal proteins with 
(merged) subcellular location annotations in the UniProtKB subcellular location comments, 
UniProtKB subcellular component GO terms and LOCATE Subcellular Location database. 
(left) Distribution of the 299 bimodal proteins in the initial data set over different 
combinations of sucrose gradient fractions. The indicated combinations of fractions can only 
arise for proteins with at least two different subcellular locations. (right) Summary of the 
(merged) subcellular location annotations for all 299 bimodal proteins. The annotations are 
color coded (legend) according to the GO classification levels compatible with our 
experimental strategy (upper: extracellular region, plasma membrane, cytoplasm, nucleus; 
lower: cytosol/cytoplasm, endoplasmic reticulum, Golgi apparatus, mitochondrion). A 
small number of proteins had multiple lower level annotations and are shown in the region 
color coded as multiple. Proteins that had multiple annotations that included other locations 
different from the color code are indicated by the radial letters. Slices that have color coded 
radial lettering are those corresponding to proteins whose annotations indicate multiple 
subcellular locations within the GO classification levels of our experimental design. 
Over all of the 2184 proteins, the annotations at the subcellular level in the examined 
databases tend to be to single locations. Given that many previous proteomics studies were 
biased against detection of proteins in multiple locations (e.g., studies of purified organelles) 
and that annotations at sub-cytoplasmic levels are clearly still very sparse, we consider that 
the previously available annotations of experimental data are not inconsistent with the 
proposal that many, probably a sizable majority, of the proteins have multiple subcellular 
locations. Using the initial data set of (protein, fraction) pairs, there were a relatively small 
number of discrepancies between our data and previous annotations of subcellular location 
in the two databases. Of the 1441 proteins identified in fraction ER, there were a total of 33 
proteins previously annotated to endoplasmic reticulum that we did not observe in fraction 
ER. Similarly for fractions PM (1611 proteins) and MT (1610 proteins), there were a total of 
58 and 29 proteins previously annotated to plasma membrane and mitochondrion 
respectively that we did not observe in the corresponding gradient fraction. 
Inconsistencies in the databases might contribute to the apparent discrepancies. For the 2184 
proteins identified here, Figure 8 shows the status of annotations of plasma membrane (443 
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proteins), mitochondrion (168) and endoplasmic reticulum (243) proteins. There is rather 
little concordance between the annotation sets, which presumably must reflect the inclusion 
of very different experimental data sets.  
 
 
Fig. 8. Venn diagrams comparing the status of annotations of subcellular locations in the 
UniProtKB subcellular location components, UniProtKB cellular component GO terms and 
LOCATE Subcellular Location database for proteins observed in this work. 443 proteins 
annotated as plasma membrane. 168 proteins annotated as mitochondrion. 243 proteins 
annotated as endoplasmic reticulum. 
Only 8 of the 443 proteins with annotations of plasma membrane were so annotated in all 
three data sets! For the proteins annotated to plasma membrane, endoplasmic reticulum and 
mitochondrion that we did not observe in the corresponding gradient fractions, our data 
would suggest different primary locations for these 120 proteins, but does not exclude their 
presence in the annotated subcellular locations as secondary locations which could not be 
detected at our sensitivity limits. We believe that some occurrences of apparent 
discrepancies are almost inevitable for three reasons. First, there is still very little 
information about whether subcellular distributions of proteins are the same in different cell 
types or under different cellular conditions. Second, many experiments do not distinguish 
between different isoforms of the same protein, which may have different subcellular 
distributions. Indeed, the present data set includes these proteins, which in part show 
different distributions over subcellular locations for isoforms of the same protein. This data 
will be analyzed in a separate paper. Third, the databases attempt to aggregate data from 
experimental strategies with very different sensitivity, selectivity, dynamic range, and 
coverage of proteins. Targeted searches for individual proteins in purified subcellular 
fractions with antibody methods probably have the highest sensitivity for detecting trace 
amounts of proteins in any specified location, even if the trace is a tiny proportion of the 
total protein abundance. Conversely, some high throughput methods may have limited 
www.intechopen.com
 Breast Cancer – Recent Advances in Biology, Imaging and Therapeutics 
 
216 
resolution for some subcellular locations, for example, distinguishing cytosol from 
cytoplasm, and may have insufficient sensitivity and dynamic range to detect trace amounts 
of proteins in specific locations. Aggregating subcellular location information from many 
cell types and conditions obtained with very different experimental strategies, many of 
which do not distinguish protein isoforms, then becomes a very tricky task which seems 
likely to produce some discrepancies with any specific experimental method/data set. 
Although only a few of the fractions from the sucrose density gradient have been analyzed, 
the normal data set provides clear evidence that a minimum of 543 of the 2184 proteins 
(24.9%) show multiple locations. The minimum estimate is based on those proteins that are 
either present in all fractions or show bimodal distributions with abundance peaks in 
nonadjacent fractions of the sucrose gradient (Figure 3B, C). For the 321 proteins (14.7%) that 
were found only in adjacent fractions of the gradient (i.e., CT-PM, PM-ER, and ER-MT), the 
present experiments are insufficient to exclude that this might be due to the presence of a 
single organelle that occupies an intermediate position between the two fractions. On the 
other hand, we intentionally spaced the analyzed fractions widely in the sucrose gradient 
and for the 476 proteins (21.8%) that were found in three adjacent fractions (i.e., CT-PM-ER, 
or PM-ER-MT), it is improbable that these proteins have single subcellular locations. 
Especially since other proteins demonstrated lack of overlap (e.g., proteins in fractions CT-
ER or PM-MT) and lack of tailing in the sucrose gradient (Table 2). Furthermore, in most 
cases the relative abundances for the proteins observed in three adjacent fractions were 
substantial and did not correspond to trace proportions. Thus, the normal data set provides 
evidence indicating that 38.6% of the proteins may have unique locations, 24.9% certainly 
have multiple locations, 21.8% most likely have multiple locations and 14.7% may have 
either unique or multiple locations. We have used the observed set of proteins to examine 
possible connections between subcellular location and function as related to breast cancer. 
Many of the proteins observed in our experiments have previously been annotated with 
functional information. 
2.1.6 Breast cancer related proteins 
Biological process annotations for 1673 proteins, molecular function annotations for 1980 
proteins, Reactome Pathway annotations for 176 proteins and posttranslational modification 
annotations for 1653 proteins were available in the UniProtKB database. We used the 
BioBase Biological Databases, BIOBASE Knowledge Library (BKL) and ExPlainTM 2.3 
platform to identify 94 proteins in our data set that are known or suspected to be implicated 
in breast cancer via disease molecular mechanism, diagnostic marker and therapeutic target 
association. These proteins were examined for common Gene Ontology 
(http://www.geneontology.org) biological process and molecular function terms and for 
common Reactome Pathway (http://www.reactome.org) terms, which were then used as 
lures to obtain the set of proteins identified in this study that share the same terms. A 
majority of the proteins implicated in breast cancer were related to five high level cellular 
processes that involved a subset of 519 proteins observed in our experiments: apoptosis (68 
proteins), cell growth (127), signaling (131), cell interaction (62), and protein processing 
(230). 93 proteins were involved in more than one of the five processes. Figure 9 shows how 
the proteins associated with each cellular process are distributed over the subcellular 
locations using the initial data set. The striking features are that each process is distributed 
over all four locations, as might be anticipated for regulated processes, and that for all of the 
cellular processes there is an appreciable majority of proteins with 3-4 subcellular locations 
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(ranging from 54.8% for cell interaction to 66.5% for protein processing). Furthermore, the 
latter characteristic was most pronounced for the 93 proteins that were involved in more 
than one of the high level cellular processes (68.8%) 
 
 
Fig. 9. Four-way Venn diagrams summarizing the distribution of the breast-cancer-related 
set of 519 proteins over the subcellular locations for the cellular processes: signaling (131 
proteins), cell growth (127), protein processing (230), apoptosis (68 proteins), and cell 
interaction (62), as well as for proteins involved in more than one of these cellular processes 
(93). The shaded regions of the diagrams correspond to proteins with 3 or 4 locations. 
3. Conclusion  
Large scale and quantitative proteomics analysis of subcellular organelles revealed 268 
nuclear proteins and 22 extracellular region proteins that were found in various sucrose 
gradient fractions, but which had previously only been annotated experimentally to the 
nucleus and extracellular region respectively. Another 271 proteins that we detected had no 
prior annotation at either the upper level (cytoplasm, plasma membrane) or lower level 
(cytosol, endoplasmic reticulum, mitochondria) of our experimental strategy. The present 
experiments were not designed to obtain specific annotations at the lower level, e.g. to 
mitochondrion. Hence, observation of a protein in a Fraction MT that is enriched in 
mitochondrial proteins should presently only be taken as an indication and not as proof of 
its presence in mitochondria. Nonetheless, the present experiments gave several hundred  
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new location annotations at the level (plasma membrane, cytoplasm). There are several 
ways the limits on MS detection sensitivity may influence the number of locations in which 
the proteins were observed. In particular, for the highest abundance proteins, the sensitivity 
and dynamic range of the MS spectral counting methods are such that trace amounts as 
small as about 0.2% of a protein in a secondary location could be detected. As shown above 
for the normal data set, trace amounts of abundant proteins in secondary locations do not 
strongly influence estimates of the proportion of proteins with multiple subcellular 
locations. Conversely, the proportion of a protein which must be present in a secondary 
location to be detectable increases as the overall abundance of the proteins decreases, for 
example, for the lowest abundance proteins, only the highest abundance, primary location 
falls within the detection limits of the MS methods. Furthermore, for lower abundance 
proteins or for trace proportions of proteins in specific fractions, the sampling constraints on 
spectral counting that result from MS/MS sequencing of only the more abundant peptides 
means that only one peptide may be counted in some fractions. For example, there were 847 
(38.8%) proteins classified as “unique” (observed in a single fraction) in the normal data set, 
but only 481 (22.0%) in the initial data set. This difference corresponds to proteins in various 
gradient fractions that were only counted with a single peptide and 1 or 2 spectral counts. 
This means that estimations of multiple locations based on the normal data set are very 
conservative and certainly underestimate, probably strongly, the proportion of proteins 
with multiple subcellular locations. Given that estimates based on the normal data set 
provide evidence for multiple locations of at least 46.7% of the observed proteins, we 
conclude that a substantial majority of the proteins observed have multiple subcellular 
locations. Given that only 22% of proteins were seen solely in a single fraction in the initial 
data set, perhaps as much as 75% of the proteins have multiple locations. We noted above 
that 120 proteins had annotations to subcellular locations that we did not observe in the 
corresponding sucrose gradient fractions (33 to endoplasmic reticulum, 58 to plasma 
membrane and 29 to mitochondrion). We suggested that these discrepancies were not 
inconsistent with our data if the annotations corresponded to secondary locations. On the 
basis of the observed spectral counts, there are 39 of these proteins for which our data 
suggest that the previous annotations correspond to proteins with functional significance in 
a secondary location, but that >80% of the protein is in a different primary location. This 
kind of analysis can be extended to many other proteins where the functional activity and 
the measured mole fractions indicate functional roles at secondary locations. Indeed, some 
of the proteins that we detected at trace amounts (<3%) in secondary locations already have 
known functions at those locations. The present experiments thus indicate numerous 
proteins with primary locations which probably differ from current function/location 
annotations and for which confirmation of the primary location (and potentially of other 
functional activities) might be profitably sought. The present experiments suggest 1383 
(protein, location, function) data points for 519 proteins involved in five major cellular 
functional processes for which investigation of functional roles might further elucidate 
mechanisms involved in breast cancer. This is a very promising situation for experiments 
aimed at investigating dynamic changes in the spatio/temporal location/form of proteins in 
breast cancer cells, their potential roles in regulation and their potential importance in breast 
cancer disease. Finally, in summary, we have found evidence that strongly suggests a 
majority of the detected proteins have multiple subcellular locations in the breast cancer 
model MCF-7 cells, that even with a fairly simple experiment a wealth of new annotation 
data can be obtained, that available evidence suggests that for many proteins distribution 
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over multiple subcellular locations can be important to their functional roles, and that large 
numbers of (protein, location) pairs deserving of further investigation of 
functional/regulatory roles can be delineated. We are still very far from having good static 
descriptions of the spatial distributions of cellular proteins, let alone dynamic information 
on relationships between spatio/temporal distribution and function. However, high-
throughput proteomics in combination with other experimental methods seems to offer 
ways forward. 
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